Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc.

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Medtronic, with a price target of $111.00. The company’s sh...

Medtronic (MDT) Receives a Buy from Bernstein

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cooper Co (COO – Research Report) and Medtronic (MDT...

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO) and Medtronic (MDT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pliant Therapeutics (PLRX – Research Report), uniQ...

Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), uniQure (QURE) and Medtronic (MDT)

Medtronic (MDT) Receives a Hold from Piper Sandler

An announcement from Electrolux AB ( ($SE:ELUX.B) ) is now available. Electrolux Group hosted a Capital Markets Update to present its updated strat...

Electrolux Group Unveils Updated Strategy and Reaffirms Financial Targets

Zoomd Technologies Ltd. ( ($ZMDTF) ) has released its Q3 earnings. Here is a breakdown of the information Zoomd Technologies Ltd. presented to its ...

Zoomd Technologies Reports Strong Q3 2025 Profit Growth

Insiders have been trading these 5 stocks: (($TEVA)), (($AMGN)), (($RITM)), (($FSLY)) and (($MDT)). Here is a breakdown of their recent trades and ...

Teva, Amgen, Rithm, Fastly, Medtronic: Major Stock Moves!

Analysts are intrested in these 5 stocks: ( ($QS) ), ( ($MDT) ), ( ($MP) ), ( ($CSIQ) ) and ( ($AVAV) ). Here is a breakdown of their recent


QuantumScape, Medtronic, MP Materials, Canadian Solar, AeroVironment: Trending by Analysts

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zymeworks (ZYME – Research Report) and Medtronic (...

Market Cap	$122.86B	P/E Ratio	17.68
52W High	$106.33	52W Low	$79.29
Div Yield	284.0%	Payout Ratio	311.1%
EPS Growth 3Y	-1.1%	52W Position	76.1%
Overall Score	81	Value Score	100
Quality Score	63	Technical Score	81

EPS Current Est	$5.65	EPS Next Est	$6.13
EPS Growth Est	+8.5%	DPS Growth 3Y	3.6%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$99.87	+0.12%	6.55M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$99.87	+0.1%	6.55M
3
4
5
6

MDT

MDT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Medtronic plc. Data in Excel

Get Medtronic plc. Data in Excel